Uniphar Group PLC Total Liabilities
Uniphar Group PLC total liabilities. Based on the latest financial reports, Uniphar Group PLC (UPR) has total liabilities worth €1.19 Billion EUR (≈ $1.39 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Uniphar Group PLC to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Uniphar Group PLC (2016–2024)
Total liabilities of Uniphar Group PLC from 2016 to 2024. This chart illustrates how Uniphar Group PLC's total liabilities have evolved over time, based on quarterly financial data.
Uniphar Group PLC Competitors by Total Liabilities
The table below lists competitors of Uniphar Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jubilant Ingrevia Limited
NSE:JUBLINGREA
|
India | Rs22.16 Billion |
|
Berliner Effektengesellschaft AG
F:BFV
|
Germany | €242.01 Million |
|
Ho Chi Minh City Securities Corp
VN:HCM
|
Vietnam | ₫31.96 Trillion |
|
Gentherm Inc
NASDAQ:THRM
|
USA | $770.09 Million |
|
Mivtach Shamir
TA:MISH
|
Israel | ILA4.00 Billion |
|
Cangzhou Mingzhu Plastic Co Ltd
SHE:002108
|
China | CN¥3.33 Billion |
|
Yindu Kitchen Equipment Co Ltd
SHG:603277
|
China | CN¥1.28 Billion |
|
Equital
TA:EQTL
|
Israel | ILA12.89 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Uniphar Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Uniphar Group PLC total assets.
Liquidity & Leverage Metrics
Uniphar Group PLC Total Liabilities Ratios Explained
Uniphar Group PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.76 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Uniphar Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Uniphar Group PLC (2016–2024)
The table below shows the annual total liabilities of Uniphar Group PLC from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.01 Billion ≈ $1.19 Billion |
+6.07% |
| 2023-12-31 | €955.94 Million ≈ $1.12 Billion |
+16.43% |
| 2022-12-31 | €821.01 Million ≈ $959.85 Million |
+18.40% |
| 2021-12-31 | €693.43 Million ≈ $810.69 Million |
+8.70% |
| 2020-12-31 | €637.92 Million ≈ $745.80 Million |
+10.04% |
| 2019-12-31 | €579.70 Million ≈ $677.73 Million |
+14.57% |
| 2018-12-31 | €506.00 Million ≈ $591.57 Million |
+68.52% |
| 2017-12-31 | €300.25 Million ≈ $351.03 Million |
+0.82% |
| 2016-12-31 | €297.81 Million ≈ $348.18 Million |
-- |
About Uniphar Group PLC
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more